Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Histological and molecular characterization of TFEB-rearranged renal cell carcinomas.

Wyvekens N, Rechsteiner M, Fritz C, Wagner U, Tchinda J, Wenzel C, Kuithan F, Horn LC, Moch H.

Virchows Arch. 2019 May;474(5):625-631. doi: 10.1007/s00428-019-02526-8. Epub 2019 Jan 31.

PMID:
30706129
2.

Microarray-based comparative genomic hybridisation reveals additional recurrent aberrations in adult patients evaluated for myelodysplastic syndrome with normal karyotype.

Ouahchi I, Zhang L, Benitez Brito R, Benz R, Müller R, Bonadies N, Tchinda J.

Br J Haematol. 2019 Jan;184(2):282-287. doi: 10.1111/bjh.15068. Epub 2018 Jan 9. No abstract available.

PMID:
29318588
3.

Intragenic amplification of PAX5: a novel subgroup in B-cell precursor acute lymphoblastic leukemia?

Schwab C, Nebral K, Chilton L, Leschi C, Waanders E, Boer JM, Žaliová M, Sutton R, Öfverholm II, Ohki K, Yamashita Y, Groeneveld-Krentz S, Froňková E, Bakkus M, Tchinda J, Barbosa TDC, Fazio G, Mlynarski W, Pastorczak A, Cazzaniga G, Pombo-de-Oliveira MS, Trka J, Kirschner-Schwabe R, Imamura T, Barbany G, Stanulla M, Attarbaschi A, Panzer-Grümayer R, Kuiper RP, den Boer ML, Cavé H, Moorman AV, Harrison CJ, Strehl S.

Blood Adv. 2017 Aug 14;1(19):1473-1477. doi: 10.1182/bloodadvances.2017006734. eCollection 2017 Aug 22.

4.

Genotype-outcome correlations in pediatric AML: the impact of a monosomal karyotype in trial AML-BFM 2004.

Rasche M, von Neuhoff C, Dworzak M, Bourquin JP, Bradtke J, Göhring G, Escherich G, Fleischhack G, Graf N, Gruhn B, Haas OA, Klingebiel T, Kremens B, Lehrnbecher T, von Stackelberg A, Tchinda J, Zemanova Z, Thiede C, von Neuhoff N, Zimmermann M, Creutzig U, Reinhardt D.

Leukemia. 2017 Dec;31(12):2807-2814. doi: 10.1038/leu.2017.121. Epub 2017 Apr 25.

5.

Ex vivo drug response profiling detects recurrent sensitivity patterns in drug-resistant acute lymphoblastic leukemia.

Frismantas V, Dobay MP, Rinaldi A, Tchinda J, Dunn SH, Kunz J, Richter-Pechanska P, Marovca B, Pail O, Jenni S, Diaz-Flores E, Chang BH, Brown TJ, Collins RH, Uhrig S, Balasubramanian GP, Bandapalli OR, Higi S, Eugster S, Voegeli P, Delorenzi M, Cario G, Loh ML, Schrappe M, Stanulla M, Kulozik AE, Muckenthaler MU, Saha V, Irving JA, Meisel R, Radimerski T, Von Stackelberg A, Eckert C, Tyner JW, Horvath P, Bornhauser BC, Bourquin JP.

Blood. 2017 Mar 16;129(11):e26-e37. doi: 10.1182/blood-2016-09-738070. Epub 2017 Jan 25.

6.

Identification of oncogenic driver mutations by genome-wide CRISPR-Cas9 dropout screening.

Kiessling MK, Schuierer S, Stertz S, Beibel M, Bergling S, Knehr J, Carbone W, de Vallière C, Tchinda J, Bouwmeester T, Seuwen K, Rogler G, Roma G.

BMC Genomics. 2016 Sep 9;17(1):723. doi: 10.1186/s12864-016-3042-2.

7.

Changes in cytogenetics and molecular genetics in acute myeloid leukemia from childhood to adult age groups.

Creutzig U, Zimmermann M, Reinhardt D, Rasche M, von Neuhoff C, Alpermann T, Dworzak M, Perglerová K, Zemanova Z, Tchinda J, Bradtke J, Thiede C, Haferlach C.

Cancer. 2016 Dec 15;122(24):3821-3830. doi: 10.1002/cncr.30220. Epub 2016 Aug 16.

8.

Explant culture of sarcoma patients' tissue.

Muff R, Botter SM, Husmann K, Tchinda J, Selvam P, Seeli-Maduz F, Fuchs B.

Lab Invest. 2016 Jul;96(7):752-62. doi: 10.1038/labinvest.2016.49. Epub 2016 Apr 25.

9.

Genomics and drug profiling of fatal TCF3-HLF-positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options.

Fischer U, Forster M, Rinaldi A, Risch T, Sungalee S, Warnatz HJ, Bornhauser B, Gombert M, Kratsch C, Stütz AM, Sultan M, Tchinda J, Worth CL, Amstislavskiy V, Badarinarayan N, Baruchel A, Bartram T, Basso G, Canpolat C, Cario G, Cavé H, Dakaj D, Delorenzi M, Dobay MP, Eckert C, Ellinghaus E, Eugster S, Frismantas V, Ginzel S, Haas OA, Heidenreich O, Hemmrich-Stanisak G, Hezaveh K, Höll JI, Hornhardt S, Husemann P, Kachroo P, Kratz CP, Te Kronnie G, Marovca B, Niggli F, McHardy AC, Moorman AV, Panzer-Grümayer R, Petersen BS, Raeder B, Ralser M, Rosenstiel P, Schäfer D, Schrappe M, Schreiber S, Schütte M, Stade B, Thiele R, von der Weid N, Vora A, Zaliova M, Zhang L, Zichner T, Zimmermann M, Lehrach H, Borkhardt A, Bourquin JP, Franke A, Korbel JO, Stanulla M, Yaspo ML.

Nat Genet. 2015 Sep;47(9):1020-1029. doi: 10.1038/ng.3362. Epub 2015 Jul 27.

10.

Successful Combination of Sequential Gene Therapy and Rescue Allo-HSCT in Two Children with X-CGD - Importance of Timing.

Siler U, Paruzynski A, Holtgreve-Grez H, Kuzmenko E, Koehl U, Renner ED, Alhan C, de Loosdrecht AA, Schwäble J, Pfluger T, Tchinda J, Schmugge M, Jauch A, Naundorf S, Kühlcke K, Notheis G, Güngor T, Kalle CV, Schmidt M, Grez M, Seger R, Reichenbach J.

Curr Gene Ther. 2015;15(4):416-27.

PMID:
25981636
11.

An international study of intrachromosomal amplification of chromosome 21 (iAMP21): cytogenetic characterization and outcome.

Harrison CJ, Moorman AV, Schwab C, Carroll AJ, Raetz EA, Devidas M, Strehl S, Nebral K, Harbott J, Teigler-Schlegel A, Zimmerman M, Dastuge N, Baruchel A, Soulier J, Auclerc MF, Attarbaschi A, Mann G, Stark B, Cazzaniga G, Chilton L, Vandenberghe P, Forestier E, Haltrich I, Raimondi SC, Parihar M, Bourquin JP, Tchinda J, Haferlach C, Vora A, Hunger SP, Heerema NA, Haas OA; Ponte di Legno International Workshop in Childhood Acute Lymphoblastic Leukemia.

Leukemia. 2014 May;28(5):1015-21. doi: 10.1038/leu.2013.317. Epub 2013 Oct 29.

12.

Double hit, triple hit--look for it.

Benz R, Tchinda J.

Blood. 2013 Mar 28;121(13):2383. No abstract available.

13.

Long-term transfusion independence in del(5q) MDS patients after short term therapy with lenalidomide: 2 new cases.

Himmelmann A, Tchinda J.

Leuk Res. 2012 May;36(5):656-7. doi: 10.1016/j.leukres.2011.11.023. Epub 2011 Dec 17. No abstract available.

PMID:
22177945
14.

Xenografts of highly resistant leukemia recapitulate the clonal composition of the leukemogenic compartment.

Schmitz M, Breithaupt P, Scheidegger N, Cario G, Bonapace L, Meissner B, Mirkowska P, Tchinda J, Niggli FK, Stanulla M, Schrappe M, Schrauder A, Bornhauser BC, Bourquin JP.

Blood. 2011 Aug 18;118(7):1854-64. doi: 10.1182/blood-2010-11-320309. Epub 2011 Jun 13.

15.

Comparison of familial and sporadic chronic lymphocytic leukaemia using high resolution array comparative genomic hybridization.

Setlur SR, Ihm C, Tchinda J, Shams S, Werner L, Cho EK, Thompson C, Phillips K, Rassenti LZ, Kipps TJ, Neuberg D, Freedman AS, Lee C, Brown JR.

Br J Haematol. 2010 Nov;151(4):336-45. doi: 10.1111/j.1365-2141.2010.08341.x. Epub 2010 Aug 31.

16.

Targeted therapeutic approach for an anaplastic thyroid cancer in vitro and in vivo.

Stenner F, Liewen H, Zweifel M, Weber A, Tchinda J, Bode B, Samaras P, Bauer S, Knuth A, Renner C.

Cancer Sci. 2008 Sep;99(9):1847-52. doi: 10.1111/j.1349-7006.2008.00882.x. Epub 2008 Jul 4.

17.

The recurrent SET-NUP214 fusion as a new HOXA activation mechanism in pediatric T-cell acute lymphoblastic leukemia.

Van Vlierberghe P, van Grotel M, Tchinda J, Lee C, Beverloo HB, van der Spek PJ, Stubbs A, Cools J, Nagata K, Fornerod M, Buijs-Gladdines J, Horstmann M, van Wering ER, Soulier J, Pieters R, Meijerink JP.

Blood. 2008 May 1;111(9):4668-80. doi: 10.1182/blood-2007-09-111872. Epub 2008 Feb 25.

18.

Alu elements mediate MYB gene tandem duplication in human T-ALL.

O'Neil J, Tchinda J, Gutierrez A, Moreau L, Maser RS, Wong KK, Li W, McKenna K, Liu XS, Feng B, Neuberg D, Silverman L, DeAngelo DJ, Kutok JL, Rothstein R, DePinho RA, Chin L, Lee C, Look AT.

J Exp Med. 2007 Dec 24;204(13):3059-66. Epub 2007 Dec 10.

19.

Molecular characterization of TMPRSS2-ERG gene fusion in the NCI-H660 prostate cancer cell line: a new perspective for an old model.

Mertz KD, Setlur SR, Dhanasekaran SM, Demichelis F, Perner S, Tomlins S, Tchinda J, Laxman B, Vessella RL, Beroukhim R, Lee C, Chinnaiyan AM, Rubin MA.

Neoplasia. 2007 Mar;9(3):200-6.

20.

Inducible Cre/loxP recombination in the mouse proximal tubule.

Dworniczak B, Skryabin B, Tchinda J, Heuck S, Seesing FJ, Metzger D, Chambon P, Horst J, Pennekamp P.

Nephron Exp Nephrol. 2007;106(1):e11-20. Epub 2007 Mar 12.

PMID:
17356303
21.

Array-based comparative genomic hybridization and copy number variation in cancer research.

Cho EK, Tchinda J, Freeman JL, Chung YJ, Cai WW, Lee C.

Cytogenet Genome Res. 2006;115(3-4):262-72. Review.

PMID:
17124409
22.

Global variation in copy number in the human genome.

Redon R, Ishikawa S, Fitch KR, Feuk L, Perry GH, Andrews TD, Fiegler H, Shapero MH, Carson AR, Chen W, Cho EK, Dallaire S, Freeman JL, González JR, Gratacòs M, Huang J, Kalaitzopoulos D, Komura D, MacDonald JR, Marshall CR, Mei R, Montgomery L, Nishimura K, Okamura K, Shen F, Somerville MJ, Tchinda J, Valsesia A, Woodwark C, Yang F, Zhang J, Zerjal T, Zhang J, Armengol L, Conrad DF, Estivill X, Tyler-Smith C, Carter NP, Aburatani H, Lee C, Jones KW, Scherer SW, Hurles ME.

Nature. 2006 Nov 23;444(7118):444-54.

23.

Detecting copy number variation in the human genome using comparative genomic hybridization.

Tchinda J, Lee C.

Biotechniques. 2006 Oct;41(4):385, 387, 389 passim.

24.

TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer.

Perner S, Demichelis F, Beroukhim R, Schmidt FH, Mosquera JM, Setlur S, Tchinda J, Tomlins SA, Hofer MD, Pienta KG, Kuefer R, Vessella R, Sun XW, Meyerson M, Lee C, Sellers WR, Chinnaiyan AM, Rubin MA.

Cancer Res. 2006 Sep 1;66(17):8337-41.

25.

Double induction containing either two courses or one course of high-dose cytarabine plus mitoxantrone and postremission therapy by either autologous stem-cell transplantation or by prolonged maintenance for acute myeloid leukemia.

Büchner T, Berdel WE, Schoch C, Haferlach T, Serve HL, Kienast J, Schnittger S, Kern W, Tchinda J, Reichle A, Lengfelder E, Staib P, Ludwig WD, Aul C, Eimermacher H, Balleisen L, Sauerland MC, Heinecke A, Wörmann B, Hiddemann W.

J Clin Oncol. 2006 Jun 1;24(16):2480-9. Erratum in: J Clin Oncol. 2011 Jul 1;29(19):2739.

PMID:
16735702
26.

Hotspots for copy number variation in chimpanzees and humans.

Perry GH, Tchinda J, McGrath SD, Zhang J, Picker SR, Cáceres AM, Iafrate AJ, Tyler-Smith C, Scherer SW, Eichler EE, Stone AC, Lee C.

Proc Natl Acad Sci U S A. 2006 May 23;103(21):8006-11. Epub 2006 May 15.

27.

Novel three-break rearrangement and cryptic translocations leading to colocalization of MYC and IGH signals in B-cell acute lymphoblastic leukemia.

Tchinda J, Volpert S, Berdel WE, Büchner T, Horst J.

Cancer Genet Cytogenet. 2006 Mar;165(2):180-4.

PMID:
16527615
28.

[Cytogenetic alterations in renal tumors. Applications for comparative genomic hybridization and fluorescence in situ hybridization].

Mertz KD, Tchinda J, Küfer R, Möller P, Rubin MA, Moch H, Perner S.

Urologe A. 2006 Mar;45(3):316-8, 320-2. Review. German.

PMID:
16465524
29.

Targeting receptor kinases by a novel indolinone derivative in multiple myeloma: abrogation of stroma-derived interleukin-6 secretion and induction of apoptosis in cytogenetically defined subgroups.

Bisping G, Kropff M, Wenning D, Dreyer B, Bessonov S, Hilberg F, Roth GJ, Munzert G, Stefanic M, Stelljes M, Scheffold C, Müller-Tidow C, Liebisch P, Lang N, Tchinda J, Serve HL, Mesters RM, Berdel WE, Kienast J.

Blood. 2006 Mar 1;107(5):2079-89. Epub 2005 Nov 8.

30.

Treatment of AML in biological subgroups.

Buechner T, Berdel WE, Schoch C, Haferlach T, Serve HL, Schnittger S, Kern W, Tchinda J, Reichle A, Staib P, Ludwig WD, Aul C, Sauerland MC, Heinecke A, Woermann B, Hiddemann W; German Acute Myeloid Leukemia Cooperative Group (AMLCG).

Hematology. 2005;10 Suppl 1:281-85. Review. No abstract available.

PMID:
16276628
31.

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, Sun XW, Varambally S, Cao X, Tchinda J, Kuefer R, Lee C, Montie JE, Shah RB, Pienta KJ, Rubin MA, Chinnaiyan AM.

Science. 2005 Oct 28;310(5748):644-8.

32.

Acute myeloid leukemia presenting with a uterus tumor.

Albrecht O, Serve H, Tchinda J, Zühlsdorf M, Büchner T, Bremer C, Parwaresch R, Berdel WE.

Ann Hematol. 2006 Jan;85(1):58-9. Epub 2005 Oct 20. No abstract available.

PMID:
16237527
33.

Bortezomib in combination with dexamethasone for relapsed multiple myeloma.

Kropff MH, Bisping G, Wenning D, Volpert S, Tchinda J, Berdel WE, Kienast J.

Leuk Res. 2005 May;29(5):587-90. Epub 2005 Jan 15.

PMID:
15755512
34.

Frequent gains of the short arm of chromosome 9 in multiple myeloma with normal G-banded karyotype detected by comparative genomic hybridization.

Tchinda J, Volpert S, Kropff M, Berdel WE, Kienast J, Meinhardt F, Horst J.

Am J Clin Pathol. 2004 Dec;122(6):875-82.

PMID:
15539380
35.

Prediction of relapse of acute myeloid leukemia in allogeneic transplant recipients by marrow CD34+ donor cell chimerism analysis.

Scheffold C, Kroeger M, Zuehlsdorf M, Tchinda J, Silling G, Bisping G, Stelljes M, Buechner T, Berdel WE, Kienast J.

Leukemia. 2004 Dec;18(12):2048-50. No abstract available.

PMID:
15470491
36.

Characterization of chromosomal rearrangements in hematological diseases using spectral karyotyping.

Tchinda J, Neumann TE, Volpert S, Berdel WE, Büchner T, Horst J.

Diagn Mol Pathol. 2004 Sep;13(3):190-5.

PMID:
15322432
37.
38.

Multicolor karyotyping in acute myeloid leukemia.

Tchinda J, Volpert S, McNeil N, Neumann T, Kennerknecht I, Ried T, Büchner T, Serve H, Berdel WE, Horst J, Hilgenfeld E.

Leuk Lymphoma. 2003 Nov;44(11):1843-53. Review.

PMID:
14738135
39.

A cryptic insertion (17;15) on both chromosomes 17 with lack of PML-RARA expression in a case of atypical acute promyelocytic leukemia.

Tchinda J, Volpert S, Liersch R, Zühlsdorf M, Serve H, Neumann T, Kennerknecht I, Berdel WE, Büchner T, Horst J.

Leukemia. 2004 Jan;18(1):183-6. No abstract available.

PMID:
14562122
40.
41.

Novel der(1)t(1;19) in two patients with myeloid neoplasias.

Tchinda J, Volpert S, Neumann T, Kennerknecht I, Ritter J, Büchner T, Berdel WE, Horst J.

Cancer Genet Cytogenet. 2002 Feb;133(1):61-5.

PMID:
11890991
42.

Spectral karyotyping and fluorescence in situ hybridization detect novel chromosomal aberrations, a recurring involvement of chromosome 21 and amplification of the MYC oncogene in acute myeloid leukaemia M2.

Hilgenfeld E, Padilla-Nash H, McNeil N, Knutsen T, Montagna C, Tchinda J, Horst J, Ludwig WD, Serve H, Büchner T, Berdel WE, Schröck E, Ried T.

Br J Haematol. 2001 May;113(2):305-17.

PMID:
11380393
43.
44.

Cytogenetic aberrations in myelodysplastic syndrome detected by comparative genomic hybridization and fluorescence in situ hybridization.

Wilkens L, Burkhardt D, Tchinda J, Büsche G, Werner M, Nolte M, Ganser A, Georgii A.

Diagn Mol Pathol. 1999 Mar;8(1):47-53.

PMID:
10408793
45.

Analysis of hematologic diseases using conventional karyotyping, fluorescence in situ hybridization (FISH), and comparative genomic hybridization (CGH).

Wilkens L, Tchinda J, Burkhardt D, Nolte M, Werner M, Georgii A.

Hum Pathol. 1998 Aug;29(8):833-9.

PMID:
9712425
46.

Value of fluorescence in situ hybridization for detecting the bcr/abl gene fusion in interphase cells of routine bone marrow specimens.

Werner M, Ewig M, Nasarek A, Wilkens L, von Wasielewski R, Tchinda J, Nolte M.

Diagn Mol Pathol. 1997 Oct;6(5):282-7.

PMID:
9458387
47.

Applications of single-color and double-color oligonucleotide primed in situ labeling in cytology.

Werner M, Nasarek A, Tchinda J, von Wasielewski R, Komminoth P, Wilkens L.

Mod Pathol. 1997 Nov;10(11):1164-71.

PMID:
9388069
48.

Single- and double-color oligonucleotide primed in situ labeling (PRINS): applications in pathology.

Wilkens L, Tchinda J, Komminoth P, Werner M.

Histochem Cell Biol. 1997 Oct-Nov;108(4-5):439-46. Review.

PMID:
9387936
49.

Detection of karyotype changes in interphase cells: oligonucleotide-primed in situ labelling versus fluorescence in situ hybridization.

Werner M, Wilkens L, Nasarek A, Tchinda J, Komminoth P.

Virchows Arch. 1997 May;430(5):381-7.

PMID:
9174628

Supplemental Content

Loading ...
Support Center